{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:32:58Z","timestamp":1791318778746,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1002\/jps.20728","type":"journal-article","created":{"date-parts":[[2006,8,22]],"date-time":"2006-08-22T13:46:40Z","timestamp":1156254400000},"page":"2738-2750","source":"Crossref","is-referenced-by-count":82,"title":["A Practical Approach to the use of Nanoparticles for Vaccine Delivery"],"prefix":"10.1016","volume":"95","author":[{"given":"Janet","family":"Wendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmohan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chesko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jina","family":"Kazzaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elawati","family":"Soewanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildred","family":"Ugozzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20728_bb0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/14760584.2.2.269","article-title":"Microparticles as vaccine adjuvants and delivery systems","volume":"2","author":"O'Hagan","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1002\/jps.20728_bb0015","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants\u2014In retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"10.1002\/jps.20728_bb0020","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.vaccine.2005.09.046","article-title":"A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens","volume":"24","author":"Singh","year":"2006","journal-title":"Vaccine"},{"key":"10.1002\/jps.20728_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20728_bb0030","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials"},{"key":"10.1002\/jps.20728_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-409X(97)00049-5","article-title":"Preparation of microspheres by the solvent evaporation technique","volume":"28","author":"McGinity","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20728_bb0040","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/03639049809108571","article-title":"Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers","volume":"24","author":"Quintanar-Guerrero","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.20728_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i5.20","article-title":"PLGA nanoparticles in drug delivery: The state of the art","volume":"21","author":"Bala","year":"2004","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1002\/jps.20728_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jiang","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20728_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i23.10","article-title":"Microparticles and nanoparticles as delivery systems for DNA vaccines","volume":"20","author":"Cui","year":"2003","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1002\/jps.20728_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/14760584.4.2.185","article-title":"Nanoparticles as carriers for nasal vaccine delivery","volume":"4","author":"Koping-Hoggard","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1002\/jps.20728_bb0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20728_bb0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-4615-1823-5_19","article-title":"Nanoparticles as adjuvants for vaccines","volume":"6","author":"Kreuter","year":"1995","journal-title":"Pharm Biotechnol"},{"key":"10.1002\/jps.20728_bb0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1023\/A:1011063232257","article-title":"Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): Evaluation of antibody response after oral and nasal application in mice","volume":"18","author":"Jung","year":"2001","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20728_bb0080","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.97.2.811","article-title":"Cationic microparticles: A potent delivery system for DNA vaccines","volume":"97","author":"Singh","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.20728_bb0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0168-3659(02)00275-4","article-title":"Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres","volume":"85","author":"Diwan","year":"2002","journal-title":"J Control Release"},{"key":"10.1002\/jps.20728_bb0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jps.10538","article-title":"Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B","volume":"93","author":"Singh","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20728_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/14712598.4.4.483","article-title":"Charged polylactide co-glycolide microparticles as antigen delivery systems","volume":"4","author":"Singh","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1002\/jps.20728_bb0100","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect Immun"},{"key":"10.1002\/jps.20728_bb0105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0264-410X(93)90387-D","article-title":"Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles","volume":"11","author":"O'Hagan","year":"1993","journal-title":"Vaccine"},{"key":"10.1002\/jps.20728_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"10.1002\/jps.20728_bb0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/0894268041457183","article-title":"PEG-PLA nanoparticles as carriers for nasal vaccine delivery","volume":"17","author":"Vila","year":"2004","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.20728_bb0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0142-9612(88)90033-6","article-title":"Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage","volume":"9","author":"Tabata","year":"1988","journal-title":"Biomaterials"},{"key":"10.1002\/jps.20728_bb0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1012029517394","article-title":"The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual","volume":"14","author":"Florence","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20728_bb0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20728_bb0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0168-3659(93)90103-C","article-title":"The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery","volume":"25","author":"Scholes","year":"1993","journal-title":"J Control Release"},{"key":"10.1002\/jps.20728_bb0140","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20728_bb0145","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1208\/pt030432","article-title":"The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l)lactide","volume":"3","author":"Peltonen","year":"2002","journal-title":"AAPS PharmSciTech"},{"key":"10.1002\/jps.20728_bb0150","first-page":"19","article-title":"The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design","volume":"41","author":"Wehrle","year":"1995","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"key":"10.1002\/jps.20728_bb0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/B:PHAM.0000019306.89420.f0","article-title":"Protein powders for encapsulation: A comparison of spray-freeze drying and spray drying of darbepoetin alfa","volume":"21","author":"Nguyen","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20728_bb0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/js970047r","article-title":"Drug microencapsulation by PLA\/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations","volume":"87","author":"Thomasin","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20728_bb0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/js970048j","article-title":"Drug microencapsulation by PLA\/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation","volume":"87","author":"Thomasin","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20728_bb0170","first-page":"309","article-title":"Effect of gamma-irradiation on peptide-containing hydrophilic poly(D,L-lactide-co-glycolide) microshperes","volume":"53","author":"Shameem","year":"1999","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1002\/jps.20728_bb0175","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1023\/A:1016256903322","article-title":"Gamma-irradiation effects on molecular-weight and in-vitro degradation of poly(D,L-lactide-co-glycolide) microparticles","volume":"12","author":"Hausberger","year":"1995","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20728_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0142-9612(96)00144-5","article-title":"Influence of sterilization processes on poly(epsilon-caprolactone) nanospheres","volume":"18","author":"Masson","year":"1997","journal-title":"Biomaterials"},{"key":"10.1002\/jps.20728_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0939-6411(02)00128-5","article-title":"Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy","volume":"55","author":"Konan","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.20728_bb0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5173(01)00944-9","article-title":"Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles","volume":"233","author":"Konan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20728_bb0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0032-5910(99)00182-5","article-title":"Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles","volume":"107","author":"Murakami","year":"2000","journal-title":"Powder Technol"},{"key":"10.1002\/jps.20728_bb0200","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0939-6411(97)00056-8","article-title":"Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres","volume":"43","author":"Blanco","year":"1997","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"key":"10.1002\/jps.20728_bb0205","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1211\/0022357056145","article-title":"The effect of freeze-dryiny with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles","volume":"57","author":"Bozdag","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20728_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02652049809006840","article-title":". Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique","volume":"15","author":"Quintanar-Guerrero","year":"1998","journal-title":"J Microencapsul"},{"key":"10.1002\/jps.20728_bb0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0939-6411(00)00125-9","article-title":"Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs","volume":"50","author":"Saez","year":"2000","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"key":"10.1002\/jps.20728_bb0220","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.vaccine.2003.11.071","article-title":"European union regulatory developments for new vaccine adjuvants and delivery systems","volume":"22","author":"Sesardic","year":"2004","journal-title":"Vaccine"},{"key":"10.1002\/jps.20728_bb0225","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/js970315l","article-title":"Current perspectives on pain upon injection of drugs","volume":"87","author":"Brazeau","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20728_bb0230","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/02652049709006828","article-title":"Stability of cyclosporine-loaded poly-Sigma-caprolactone nanoparticles","volume":"14","author":"Molpeceres","year":"1997","journal-title":"J Microencapsulation"},{"key":"10.1002\/jps.20728_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0378-5173(96)04618-2","article-title":"Optimized preparation of poly(D,L-lactic-glycolic) microspheres and nanoparticles for oral administration","volume":"141","author":"Chacon","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20728_bb0240","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/(SICI)1098-2299(199606)38:2<116::AID-DDR6>3.0.CO;2-M","article-title":"Freeze-drying of itraconazole-loaded nanosphere suspensions: A feasibility study","volume":"38","author":"deChasteigner","year":"1996","journal-title":"Drug Develop Res"},{"key":"10.1002\/jps.20728_bb0245","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"key":"10.1002\/jps.20728_bb0250","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1126\/science.1109869","article-title":"Identification of a universal Group B Streptococcus vaccine by multiple genome screen","volume":"309","author":"Maione","year":"2005","journal-title":"Science"},{"key":"10.1002\/jps.20728_bb0255","unstructured":"Fessi H,Puisieux F,Devissaguet JP.1987.Process for the preparation of dispersible colloidal systems of a substance in the form of nanocapsules.Eur. Patent. EP0274961."},{"key":"10.1002\/jps.20728_bb0260","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1021\/ac50154a044","article-title":"Spectrophotometric determination of polyvinyl alcohol in paper coatings","volume":"33","author":"Finley","year":"1961","journal-title":"Anal Chem"},{"key":"10.1002\/jps.20728_bb0265","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(98)00039-8","article-title":"Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics","volume":"34","author":"Allemann","year":"1998","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1002\/jps.20728_bb0270","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1002\/jps.20728_bb0275","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/078538902321117850","article-title":"Meningococcal disease: Treatment and prevention","volume":"34","author":"Wall","year":"2002","journal-title":"Ann Med"},{"key":"10.1002\/jps.20728_bb0280","first-page":"67377","article-title":"Guidance on impurities: Residual solvents","volume":"62","year":"1997","journal-title":"Fed Regist"},{"key":"10.1002\/jps.20728_bb0285","unstructured":"FDA.Inactive ingredient search for approved drug products. Accessed 12-05-05."},{"key":"10.1002\/jps.20728_bb0290","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1023\/A:1012180707283","article-title":"Rational design of stable lyophilized protein formulations: Some practical advice","volume":"14","author":"Carpenter","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20728_bb0295","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/B:PHAM.0000016234.73023.75","article-title":"Design of freeze-drying processes for pharmaceuticals: Practical advice","volume":"21","author":"Tang","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20728_bb0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.physiol.60.1.73","article-title":"The role of vitrification in anhydrobiosis","volume":"60","author":"Crowe","year":"1998","journal-title":"Annu Rev Physiol"},{"key":"10.1002\/jps.20728_bb0305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/cryo.2001.2353","article-title":"The trehalose myth revisited: Introduction to a symposium on stabilization of cells in the dry state","volume":"43","author":"Crowe","year":"2001","journal-title":"Cryobiology"},{"key":"10.1002\/jps.20728_bb0310","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-0987(98)00066-9","article-title":"Stability and freeze-drying of cyclosporine loaded poly, (lactide-glycolide) carriers","volume":"8","author":"Chacon","year":"1999","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20728_bb0315","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/PDT-100102031","article-title":"Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles","volume":"5","author":"De Jaeghere","year":"2000","journal-title":"Pharm Dev Technol"},{"key":"10.1002\/jps.20728_bb0320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","article-title":"Residual polyvinyl alcohol associated with poly(D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake","volume":"82","author":"Sahoo","year":"2002","journal-title":"J Control Release"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916321438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916321438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:44:13Z","timestamp":1587167053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916321438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0022354916321438"],"URL":"https:\/\/doi.org\/10.1002\/jps.20728","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}